I

IMIDomics Inc.

21 employees

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care

Date founded

2015

Funding rounds raised

Total raised

$17M

from 5 investors over 5 rounds

I

IMIDomics Inc. raised undisclosed on February 15, 2022

Investors: Evotec

I

IMIDomics Inc. raised $17M on July 27, 2021

Investors: DNS Capital, Bristol-Myers Squibb, UK, The Pritzker Organization and Tao Capital Partners

FAQ